Prostaglandin E2 (PGE2) Induces Headache in Healthy Subjects

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cephalalgia

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1468-2982.2008.01748.xPMID 19187340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostacyclin (epoprostenol) induces headache in healthy subjects

  2008cited by this paper
• Mast Cell Involvement in the Pathophysiology of Migraine Headache: A Hypothesis

  2006cited by this paper
• 2-methoxycinnamaldehyde reduces IL-1beta-induced prostaglandin production in rat cerebral endothelial cells.

  2006cited by this paper
• Vasoactive Intestinal Polypeptide Evokes Only a Minimal Headache in Healthy Volunteers

  2006cited by this paper
• The Headache-Inducing Effect of Cilostazol in Human Volunteers

  2006cited by this paper
• Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins

  2005cited by this paper
• Can allodynic migraine patients be identified interictally using a questionnaire?

  2005cited by this paper
• The role of Na(V)1.8 sodium channel in the maintenance of chronic inflammatory hypernociception.

  2005cited by this paper
• Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype.

  2005cited by this paper
• Terminating Migraine With Allodynia and Ongoing Central Sensitization Using Parenteral Administration of COX1/COX2 Inhibitors

  2005cited by this paper
• Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes

  2005cited by this paper
• Nrf2, a multi‐organ protector?

  2005cited by this paper
• A Report on the Journal 2004

  2004cited by this paper
• Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

  2004cited by this paper
• EP4 prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries

  2004cited by this paper
• Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate

  2004cited by this paper
• GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization

  2004cited by this paper
• Premonitory symptoms in migraine

  2003cited by this paper
• Migraine can be induced by sildenafil without changes in middle cerebral artery diameter.

  2003cited by this paper
• The International Classification of Headache Disorders: 2nd edition

  2003cited by this paper
• Pharmacokinetics of prostaglandins.

  2003cited by this paper
• Spinal EP receptors mediating prostaglandin E2-induced mechanical hyperalgesia, thermal hyperalgesia, and touch-evoked allodynia in rats.

  2003cited by this paper
• Cgrp May Play A Causative Role in Migraine

  2002cited by this paper
• Characterization of EP receptor subtypes responsible for prostaglandin E2‐induced pain responses by use of EP1 and EP3 receptor knockout mice

  2001cited by this paper
• Prostanoid receptors: ontogeny and implications in vascular physiology.

  2001cited by this paper
• Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin.

  2001cited by this paper
• Characterization of the prostanoid receptor types involved in mediating calcitonin gene‐related peptide release from cultured rat trigeminal neurones

  2001cited by this paper
• Peripheral and central sensitization during migraine.

  2000cited by this paper
• Effects of the non‐selective phosphodiesterase inhibitor pentoxifylline on regional cerebral blood flow and large arteries in healthy subjects

  2000cited by this paper
• Electrophysiological evidence for tetrodotoxin-resistant sodium channels in slowly conducting dural sensory fibers.

  1999cited by this paper
• Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro.

  1999cited by this paper
• Modulation of TTX-R INa by PKC and PKA and Their Role in PGE2-Induced Sensitization of Rat Sensory Neurons In Vitro

  1998cited by this paper
• Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis

  1998cited by this paper
• Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2

  1998cited by this paper
• Nitric Oxide Synthase Inhibition: A New Principle in the Treatment of Migraine Attacks

  1998cited by this paper
• Brain Injury Impairs Prostaglandin Cerebrovasodilation

  1998cited by this paper
• Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro

  1998cited by this paper
• Expression of prostaglandin EP2 receptor mRNA in the rat spinal cord.

  1997cited by this paper
• Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors.

  1996cited by this paper
• PGE2 modulates the tetrodotoxin‐resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP‐protein kinase A cascade.

  1996cited by this paper
• Sensitization of meningeal sensory neurons and the origin of headaches

  1996cited by this paper
• Global ischemia impairs ATP-sensitive K+ channel function in cerebral arterioles in piglets.

  1996cited by this paper
• Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammation

  1996cited by this paper
• Mast cell mediators excite the afferents of cat small intestine.

  1996cited by this paper
• An essential role of prostaglandin E on mouse mast cell induction.

  1995cited by this paper
• In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs

  1995cited by this paper
• Prostaglandin-induced neuropeptide release from spinal cord.

  1995cited by this paper
• A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks

  1994cited by this paper
• Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system.

  1994cited by this paper
• Small arteries can be accurately studied in vivo, using high frequency ultrasound.

  1993cited by this paper
• Experimental and biological variation of three-dimensional transcranial Doppler measurements.

  1993cited by this paper
• Cerebral Blood Flow and Metabolism

  1993cited by this paper
• Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography.

  1992cited by this paper
• Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.

  1992cited by this paper
• Analysis of serial measurements in medical research.

  1990cited by this paper
• Analysis of serial measurements in medical research.

  1990cited by this paper
• Cerebrovascular effects of prostanoids: in-vitro studies in feline middle cerebral and basilar artery.

  1989cited by this paper
• Effect of nitroglycerin on cerebral circulation measured by transcranial Doppler and SPECT.

  1989cited by this paper
• Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics

  1989cited by this paper
• Transport of prostaglandin D2 into brain.

  1986cited by this paper
• Regional Cerebral Blood Flow Assessed by 133Xe Inhalation and Emission Tomography: Normal Values

  1985cited by this paper
• The site of pain origin during migraine attacks J.N. Blau and S.L. Dexter, Cephalalgia, 1 (1981) 143–147

  1983cited by this paper
• Extracranial vascular changes and the source of pain in migraine headache

  1983cited by this paper
• Cerebrovascular actions of prostaglandins.

  1982cited by this paper
• The Site of Pain Origin During Migraine Attacks

  1981cited by this paper
• A Method for Calculating Regional Cerebral Blood Flow from Emission Computed Tomography of Inert Gas Concentrations

  1981cited by this paper
• Central and peripheral circulatory effects and metabolic effects of different prostaglandins given I.V. to man.

  1980cited by this paper
• Two Methods for Calculating Regional Cerebral Blood Flow from Emission Computed Tomography of Inert Gas Concentrations

  1979cited by this paper
• Index of permeability of large arteries to labeled albumin after administration of prostaglandin E2.

  1978cited by this paper

• Association between use of lubiprostone and headache: A systematic review and meta‐analysis of randomized controlled trials

  2025influential citation
• Exploring PGE2 and LXA4 Levels in Migraine Patients: The Potential of LXA4-Based Therapies

  2024cites this paper
• Association between the dietary inflammatory index and pain in US adults from NHANES

  2023cites this paper
• Common cold

  2023cites this paper
• Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2

  2022cites this paper
• Changes in Plasma Lipid Levels Following Cortical Spreading Depolarization in a Transgenic Mouse Model of Familial Hemiplegic Migraine

  2022cites this paper
• Arterial responses to infusion of Glucagon-like Peptide-1 in humans: A randomized trial study.

  2022cites this paper
• Exploring headache attributed to airplane travel

  2022influential citation
• Headaches related to latanoprost in open-angle glaucoma

  2021cites this paper
• Why does COVID‐19 pathology have several clinical forms?

  2020cites this paper
• Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers

  2020cites this paper
• Wine, food, and health

  2020cites this paper
• Migraine-provoking substances evoke periorbital allodynia in mice

  2019cites this paper
• Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication–overuse headache

  2019cites this paper
• Placebo Response in Human Models of Headache

  2019cites this paper
• What is the relative contribution of biological and psychosocial factors to the generation of hypoxia headache?

  2018cites this paper
• Aalborg Universitet Simulated airplane headache

  2017cites this paper
• Human Models of Migraine

  2017cites this paper
• Headache attributed to airplane travel: diagnosis, pathophysiology, and treatment – a systematic review

  2017influential citation
• Human models of migraine — short-term pain for long-term gain

  2017cites this paper
• Simulated airplane headache: a proxy towards identification of underlying mechanisms

  2017cites this paper
• Effect of PGD_2 on middle meningeal artery and mRNA expression profile of L-PGD_2 synthase and DP receptors in trigeminovascular system and other pain processing structures in rat brain

  2017cites this paper
• A traditional Chinese formula composed of Chuanxiong Rhizoma and Gastrodiae Rhizoma (Da Chuanxiong Formula) suppresses inflammatory response in LPS -induced RAW 264.7 cells through inhibition of NF-κB pathway.

  2017cites this paper
• Aalborg Universitet Headache attributed to airplane travel : diagnosis , pathophysiology , and treatment

  2017influential citation
• The role of monosodium glutamate in headache

  2016cites this paper
• Literature Review on The Research Trend of Clerodendri Trichotomi Folium and Relationship Between the Herbology and KCD-code

  2016cites this paper
• Review of dose–response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists

  2015cites this paper
• Microvasculature, the Trigeminal System and Migraine : A focus on female sex hormones

  2015cites this paper
• Investigating In Vivo Efficacy of Novel ALN-EP4a Conjugate Drugs for the Treatment of Post-menopausal Osteoporosis

  2014cites this paper
• COX inhibitors for the treatment of migraine

  2014cites this paper
• Symptom Progression in Acute Mountain Sickness During a 12-Hour Exposure to Normobaric Hypoxia Equivalent to 4500 M

  2014cites this paper
• Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience

  2013cites this paper
• Prostaglandins and prostaglandin receptor antagonism in migraine

  2013influential citation
• Prostaglandins and prostaglandin receptor antagonism in migraine

  2013cites this paper
• Sources of Variability of Resting Cerebral Blood Flow in Healthy Subjects: A Study Using 133Xe SPECT Measurements

  2013cites this paper
• Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies

  2013cites this paper
• Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method

  2013influential citation
• Update on future headache treatments

  2013cites this paper
• Prostaglandins in migraine: update.

  2013cites this paper
• Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38

  2012cites this paper
• 15th International Headache Congress: Basic Science Highlights

  2012cites this paper
• Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura

  2012influential citation
• Potential therapeutic interventions via EP2/EP4 prostaglandin receptors.

  2012cites this paper
• mRNA expression of 5‐hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene–related peptide in the rat trigeminovascular system

  2012cites this paper
• Involvement of Prostaglandins in the Pathophysiology of Endometriosis

  2012cites this paper
• Taking the Negative View of Current Migraine Treatments

  2012cites this paper
• Regulation of endometrial repair and its impact on heavy menstrual bleeding

  2011cites this paper
• Mechanisms of Migraine and Its Treatment

  2011cites this paper
• 16 Mechanisms of Migraine and Its Treatment

  2011cites this paper
• Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2 (PGD2)

  2011cites this paper
• Risk factors for high-altitude headache in mountaineers

  2011cites this paper
• Emerging migraine treatments and drug targets.

  2011cites this paper
• Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for Chronic Daily Headache: Protocol for a randomized clinical trial

  2011cites this paper
• Lack of correlation between vasodilatation and pharmacologically induced immediate headache in healthy subjects

  2011cites this paper
• Pro-inflammatory and vasoconstricting prostanoid PGF2α causes no headache in man

  2011cites this paper
• The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the Prostaglandin E2 human model of headache

  2011influential citation
• Inflammatory pathways in endometrial disorders.

  2011cites this paper
• What have we learnt from triggering migraine?

  2010cites this paper
• Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine

  2010cites this paper
• Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP

  2010cites this paper
• Investigation of carbachol and PACAP38 in a human model of migraine.

  2010cites this paper
• High-altitude cerebral effects: risks and mechanisms.

  2009cites this paper